Qube Research & Technologies LTD Astrazeneca PLC Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 590,541 shares of AZN stock, worth $44.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
590,541
Previous 903,412
34.63%
Holding current value
$44.5 Million
Previous $70.4 Million
45.03%
% of portfolio
0.05%
Previous 0.11%
Shares
18 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...